A procedure for the immunoassay of cohydrolase sphingolipid-I in mouse tissue is described. This cohydrolase (actually a mixture of at least four related proteins) stimulates or activates the &glucosidase which hydrolyzes ceramide glucoside, a widely occurring glycosphingolipid. The method involves extraction of cohydrolase from tissue homogenate with a salt-buffer solution, removal of proteins by adjustment to pH 6, further removal of proteins by heating, and removal of interfering materials with a small size exclusion column. Antibodies were raised to bovine cohydrolase in rabbits and purified with an alhnity column made from cohydrolase. The immunoassay involves binding of antibody by the cohydrolase sample (20-200 pg) in competition with cohydrolase that has been chemically linked to horseradish peroxidase. The mixture is treated with particle-linked second antibody and centrifuged; the pellet is then assayed thtorometrically for peroxidase content. Initial application of the method showed that cohydrolase was present in all mouse tissues studied and that its concentration paralleled that of glucocerebrosidase relatively closely. Changes with age (14 and 92 days) occurred in a similar fashion for the two substances. o 1984 Academic press, hc.
The term cohydrolase has been proposed as a generic term for the proteins which stimulate or augment the activity of various hydrolytic enzymes (I). The stimulator named cohydrolase SPH-I' acts on glucosylceramide glucosidase. It was discovered by Ho and O'Brien (2) in the spleen of a patient suffering from a genetic insufficiency of the enzyme activity (Gaucher disease). It occurs in normal spleen at a much lower level and evidently accumulates during the course of the disease, which also produces accumulation of the enzyme's substrate, glucocerebroside. The activator has been isolated from bovine (3) and human (1, 4) spleen, and has ' Abbreviations used: SPH, sphingolipid, CHS-I, cohydrolase SPH-I; PBS, 5 mM Na phosphate, pH 7, in 500 mM NaCI; IgG, immunoglobulin G, BSA, bovine serum albumin; CNBr, cyanogen bromide. been found to consist of at least four heatstable, electrophoretically separable proteins of very low molecular weight (1) . Later work showed that cohydrolase SPH-I (CHS-I) also stimulates sphingomyelinase and galactosylceramide galactosidase (5) .
The species-specificity of CHS-I seems to be low. Bovine CHS-I stimulates human and mouse glucosidases, and human CHS-I stimulates the bovine enzyme (3) .
Antibodies have been induced in rabbits, using the bovine CHS-I as antigen, and found to react to a similar degree with all four glucocerebroside cohydrolases of Gaucher spleen (1) . Initial tests with a plastic-plate binding assay showed that the antibodies also reacted with mouse extracts, suggesting that it would be possible to devise an immunoassay useful for physiological studies of cohydrolase levels.
MATERIALS AND MET HODS
Buffer A (5 I'nM Na phosphate, pH 7.0, in 40 mM NaCl) was used for storing most samples. Crude glucocerebrosidase was isolated from bovine spleen (3) and assayed with methylumbelliferyl-fi-glucoside as substrate. Tritium-labeled substrate (N-stearoyl-[6-3H]glucosylsphingosine) was prepared synthetically (6) . Hsd mice were from Harlan Sprague Dawley, Indianapolis, Indiana. Sample volumes at the microliter level were dispensed with a 5-, lo-, or 50-~1 microsyringe. This allowed us to use relatively concentrated solutions and was important for preventing losses of CHS-I by adsorption onto containers (7) . Vortexing for long periods of time (5 min or more) was done with the Kraft Big Vortexer (Glas-Co1 Apparatus, Terre Haute, Ind.), a large vortexer which holds test tubes in a rack. We made a rack for 1.5-ml polypropylene centrifuge tubes by repeatedly pushing a tube into a rectangular block of foam plastic.
Preparation of antibody. The IgG in the serum from one of the rabbits (1) was isolated with a column containing DEAE Affi-Gel Blue (Bio-Rad Laboratories, 153-7307). This is a beaded, crosslinked agarose containing diethylaminoethyl groups and covalently bound Cibacron Blue F3GA (8) . The serum (6 ml) was dialyzed against 20 mM Tris-Cl-, pH 8.0, in 28 mM NaCl, and passed through the 1.8 X 18-cm packing previously equilibrated with the same buffer. The IgG in the effluent (same buffer) was assayed in plastic titer wells by binding bovine CHS-I to the plastic, binding the antibodies to the CHS-I, and binding peroxidase-linked anti-rabbit IgG to the rabbit IgG (1). The active proteins were found to elute as a single peak, monitored at 280 nm, between 36 and 210 ml. Half-maximal color in the peroxidase assay (0.26 A) was reached with about 275 ng of the protein in the pooled fractions.
A second protein-containing peak was eluted with 20 mM Tris-Cl-, pH 8.0, containing 1.4 M NaCl. This peak yielded only the basal color in the titer-well assay at sample weights up to 1000 ng. The same negative reaction was obtained with the two peaks from control (nonimmune) serum from the same rabbit.
The active fraction was concentrated by pressure ultrafiltration with an Amicon PM 10 membrane and dialyzed against PBS. The yield was 28.6 mg of protein, based on the BSA standard in the copper-Folin reagent assay (9) .
The antibodies reacting with CHS-I were isolated from the IgG mixture with an affmity column (3.8 X 15 mm) made from 200 pg of bovine CHS-I and 100 mg of CNBractivated Sepharose 4B (7) in PBS. Various amounts of IgG ( 1.8 to 4.55 mg) were passed through the packing in 0.5 to 2 ml of PBS. Nonspecific IgG was eluted with 6 ml of PBS and bound IgG was eluted with 3 ml of 1 M HOAc in 0.5 M NaCl (this solution had a pH of 2.6). A flow rate of 5 ml/h was used and 0.5-ml fractions were collected. The acidic fractions were promptly adjusted to pH 7 with 2 M Tris base, pooled after assay, and dialyzed against PBS during vacuum ultrafiltration (p-Micro-ProDiCon Model 10, Bio-Molecular Dynamics, Ore.).
The alfmity column had a maximal binding capacity for the specific IgG of about 0.3 mg (8% of the crude IgG) and the recovery of protein in the two peaks was about 90% when a 3.7-mg sample was added to the column. In the titer-well assay for antibodies, the first protein fraction showed only the blank level of color in the peroxidase assay, while the specific fraction yielded half-maximal color at about 75 ng of IgG. Comparing this value with the corresponding value obtained after the Cibacron Blue step (275 ng), we see an enrichment in specific IgG of 3.7-fold. Based on the yield from the affinity column, however, the enrichment appears to be 12.5-fold.
Preparation of peroxidase-labeled CHS-I. Horseradish peroxidase (8 mg, Sigma Chemical Co., Type VI) was oxidized with periodate and linked to 2 mg of bovine CHS-I by reduction with borohydride (10). The conjugate, plus excess peroxidase, was separated from unreacted CHS-I with a column of Sephadex G-100 (1.6 X 80 cm) in 50 mM Tris-AcO-, pH 7.3. Elution was monitored by the ability of CHSI, even in the conjugated form, to stimulate glucosidase activity (3,ll) . The first active fraction was pooled and mixed with human serum albumin (10 mg/ ml) and then stored in 0.2~ml portions at -20°C.
Zmmunoassuyfor CZ-ZS--I. The method used (10) involves mixing an unknown or standard amount of CT-IS-1 with a standardized amount of CHS-I conjugated with peroxidase. To this is added purified IgG (too little to bind all the antigen). The antibody-antigen complex is precipitated with agarose-bound goat antibodies against rabbit IgG (Miles Laboratories), and the pellet is assayed for peroxidase content with 3-(phydroxyphenyl)propionic acid, a fluorogenic substrate ( 12) . The reaction sequence is carried out in a l&ml polypropylene conical tube with attached cap, and all materials involved in immunological binding are diluted with 0.2 M Tris-AcG, pH 7.3, containing 0.05% human serum albumin and 0.05% Tween 20. To each tube is added (in the order shown) 20 ~1 each of CHS-I (O-200 pg), IgG (100 ng), and CHS-I-peroxidase (stock solution diluted 500-fold). The competitive binding proceeds 16 h at 4"C, after which 0.2 ml of agarose-goat antibodies is added, enough to bind about 6.6 pg of rabbit IgG. The tubes are vortexed 10 min and then incubated for 3 h at 4°C. The suspension is centrifuged at 13,000g for 3 min and the pellet is washed twice with 1 ml of 50 mM Tris-acetate, pH 7.3; each time the pellet is vortexed 5 min.
The enzyme content in the final pellet is assayed by adding 1 ml of 50 mM TrisAcO-, pH 7.3, 50 ~1 of 3 mM hydrogen peroxide, and 50 ~1 of 30 IIIM hydroxyphenylpropionic acid and vortexing slowly for 1 h. Then 50 ~1 each of 0.2 M KCN and 1 M NaOH is added and the tubes are vortexed 5 min and then stored at 4°C for 16 h. After brief centrifugation, the fluorescence in the supematants is measured at 405 nm (excitation at 320 nm).
The Tris buffers were prepared at room temperature.
Assay for ghcosylceramide glucosidase activity. This was done with mouse tissue homogenates prepared in 5 mM Na phosphate, pH 7, using 4 mg of liver or 6 mg of other tissues. The procedure (14) involves a l-h incubation of labeled lipid in Triton X-100, taurocholate, and citrate-phosphate, pH 5.4, followed by solvent partitioning to isolate the radioactive glucose. The specific activities were independent of tissue weight (up to 6 mg) and time (up to 1 h).
RESULTS

Immunoassay Sensitivity
The relationship between weight of pure CHS-I and binding ratio exhibited excellent linearity and precision between 20 and 200 pg protein (Fig. 1) . 1. Relationship between weight of bovine whydrohe SPH-I and ratio of observed enzyme activities (tluoreswnce readings). The value B is the peroxidase activity when whydrolase is added to the system; B. is the activity when whydmlase is absent. The points shown for each weight indicate the values observed on 7 d&rent days, and the line connecting them is a composite of the seven standardization curves. I from Tissues   TABLE 2 Since CHS-I occurs in membranes as well as in cytosol of spleen (3), and since it binds to glucocerebrosidase (7) Note. At least two different tissue weights were assayed in duplicate and the results averaged. Minced, pooled livers were homogenized with the solutions described above, adjusted to pH 6, and centrifuged. The supematams were then heated in boiing water for 5 min, cooled, and centrifuged, and the supematant was assayed for CHS-I content.
Extraction of CHS-
Since previous trials with bovine spleen had shown a strong dependence on extraction pH at low salt concentrations (3), this matter was studied in greater detail with mouse liver. Homogenization with phosphate at pH 7 and the other steps listed above were used, but the pH after homogenization was adjusted to 4.0-6.5 instead of 6.0. In this experiment, the CHS-I extract was purified additionally, prior to assay, by passing 0.3 ml of the supematant through a 7 X 160-mm column of Sephadex G-75 (see next section). CHS-I was determined in l-, 2-, and 3-d aliquots of the CHS-I fraction (corresponding to 9.1, 18.2, and 27.3 pg of liver). The results (Table  2) show a remarkable sensitivity to extraction pH, 6.0 being best. The table also shows good proportionality to sample volume and good replication with duplicate samples.
Removal of Interfering Materials
When various amounts of liver were assayed for CHS-I content using the heated extract, the apparent concentration was seen to decrease with tissue weights greater than 14 pg. The maximal observed CHS-I concentration in the smallest aliquots was about 5.9 ng/mg, but it decreased to 3.9 ng/mg with a 27.3-pg sample of liver. Recovery tests with added pure bovine CHS-I gave values between 60 and 83%. Accordingly, an additional purification step was applied, as in the method used for CHS-I isolation (3).
the CHS-I, and the last 4 ml was inactive. Good proportionality between liver weight and CHS-I content was found, with aliquots of column effluent equivalent to 4.55-36.4 rg of liver (Table 3) . To test for the presence of interfering materials, we added 80 pg of pure bovine CHSI to similar aliquots, prior to the size exclusion step, and found good recovery with samples corresponding to liver samples up to 27.3 pg (Table 3 , right column). Table 3 also shows the severe interference with the assay due to materials in fractions A and C, which explains the need for the gel permeation step. A 7 X 160-mm (6.2 ml) column of SeAnother recovery test was made by adding phadex G-75, particle size (dry) 40-120 pm, bovine CHS-I to part of the initial liver was prepared in buffer A. A 0.3-ml sample homogenate, at the ratio of 4.5 1 ng/mg tissue, of heated liver extract, prepared as above at which almost doubled the amount of CHS-I pH 6, was passed through the column at 3 in the aliquots. The supplemented. and nonml/h and eluted with more of the same supplemented samples were centrifuged, buffer. As expected from our knowledge of heated, and purified by gel permeation as bovine and human CHS-I behavior on such above, and then three different aliquots were a column (1,3), the first 2 ml contained no assayed from each active column fraction detectable CHS-I, the next 3 ml contained (Table 4 ). These samples also showed good 36  45  12  15  7  9   102  98  124  98  166  95  206  93  244  80   46  58  24  30  18  23 Note. Fractions A, B, and C are the first, middle, and final fractions (2, 3, and 4 ml, mspeetively) obtained from a Sephadex G-75 column, 7 X 160 mm. The column was loaded with extract from 27.3 mg of mouse liver and eluted at 3 ml/h. For the interference experiments, 80 pg of bovine CHSI was added before assay to duplicate aliquots from the column fractions.
a Column effluent lirst diluted IO-fold with assay buffer. ' Column effluent first diluted 2-fold. Note. Duplicate aliquots, three different amounts, were analyzed from each column.
proportionality and recovery of added CHS-I, although some loss or interference could be seen at 27.3 gg of liver. However, the total CHS-I content from the supplemented sample (238 pg) was calculated by extrapolating from the high end of the calibration curve (Fig. I) , so a low value can be expected.
Specijicity of the Antibodies against CHS-I
The possibility always exists that some tissue proteins can react nonspecifically with the IgG isolated from immunized rabbits. While our IgG was purified by two highly specific chromatographic steps, and the samples were freed of heat-insolubilized protein, we nevertheless examined the heat-stable liver extract in greater detail. A taller Sephadex column (1.54 X 32 cm) was prepared and loaded with 3 ml of extract, as in the standard method. Fractions of 2 ml each were collected, at a flow rate of 15 ml/h, and monitored at 280 nm. As found with bovine spleen, the absorbance measurements showed an early peak, a low flat region, and a large late peak. Most of the CHS-I eluted in the intermediate low region. Immunoassay for CHS-I and evaluation of the glucocerebrosidase-stimulating activity showed single, somewhat coincident peaks for both measurements (Fig. 2) .
The concentration of CHS-I in each column fraction was calculated by the two assay methods, and the ratio of the two values, shown at the top of Fig. 2 , was found to be close to 1 at all points along the peaks. The observed fluctuations are reasonable, considering the precision of the two measurements. Thus, by definition of CHS-I as a glucosidase stimulator, the immunoassay seems to measure only CHS-I. It is possible, of course, that a high-molecular-weight pro-form of CHS-I exists in tissues, but this might be discarded by the heating or extraction step.
Glew and Coffee recently reported that calmodulin from bovine brain has a weak stimulating activity with glucocerebrosidase from human liver (13) . Our immunoassay method was applied to this protein (from bovine liver, Sigma Chemical Company, P-2277) and found to give a negative response with samples up to 1000 pg. Evidently calmodulin and CHS-I are unrelated.
Distribution of CHS-I and Glucocerebrosidase in Mouse Tissues
If the primary role of CHS-I is to activate cerebroside glucosidase, one might expect the two to be distributed similarly among different organs. They have already been shown to have a similar distribution between spleen subcellular membrane fractions (3) . In this first use of the immunoassay, we examined six tissues, pooled from ten 14day mice in two groups-of five each (Table 5) . In this experiment, CHS-I was determined in two different aliquots derived from 9.1 and 27.3 pg of tissue, each run in duplicate, the four values being averaged for use in Table 5 . Liver was found to contain the highest concentration of CHS-I and enzyme activity; heart and lung contained the lowest concentrations. The maximum range was 3.6 to 1 for glucosidase and 4.5 to 1 for CHS-I. The concentration of CHS-I in spleen was about half the values we found for bovine spleen (by isolation).
The ratio of enzyme specific activity to CHS-I content (0.82 to 1.13) was strikingly similar for all organs. (There is no signikance to the actual numerical value, which is based on arbitrary units.) Comparison of the two values for each organ on successive lines shows good agreement, considering that two different groups of mice were analyzed. The glucosidase activities were similar to those reported for CF-1 mice at age 16 (14) .
The same study with older mice (92 days) showed that both the enzyme activity and Note. Each value shown is the average of duplicate assays from one column run; each line is derived from the pooled organs from a group of five mice.
0 Bach ratio was calculated from all eight values for one organ.
CHS-I level increased with age in liver and spleen (the two organs that destroy blood cells) and decreased in brain, heart, and lung ( Table 5 ). The two levels changed with age in very similar fashions so that the ratios remained the same. Liver was consistent in possessing the lowest enzyme/CHS-I ratio at both ages.
DISCUSSION
We attribute the high precision and linearity exhibited by the immunoassay procedure described here to the use of several features: (a) antibodies that have been "sorted" by the immunopurification step to have similar binding constants; (b) reduction in adsorptive losses by the use of relatively concentrated solutions, which are dispensed with positive displacement microliter syringes; (c) avoidance of variable, nonspecific wall-binding methods and nonspecific rabbit plasma proteins; and (d) a method of small-vessel mixing which is unusually thorough (a multiple-vial vortexer).
Since CHS-I seems to activate two additional sphingolipid hydrolases (5), it will be of interest to see if there is a similar parallelism for these enzymes.
